We are live on ! Find out more
EXAC

Exactech Inc
EXAC

Delisted

EXAC was delisted on the 14th of February, 2018.

91 hedge funds and large institutions have $161M invested in Exactech Inc in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 41 increasing their positions, 21 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 21

6% more capital invested

Capital invested by funds: $152M → $161M (+$9.05M)

11% less funds holding

Funds holding: 10291 (-11)

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
91
Holders Change
-11
Holders Change %
-10.78%
% of All Funds
2.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
41
Reduced
21
Closed
17
Calls
Puts
Net Calls
Net Calls Change

EXAC Hedge Fund Activity: Q4 2015 in Review

91 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Exactech Inc (EXAC) for Q4 2015, worth a combined $161M — up 6% from $152M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of EXAC and 6 opened new positions — a net loss of 11 holders — while 21 trimmed existing stakes and 41 added.

The largest buyer was Wellington Management Group, adding an estimated $6.81M. The largest seller was Foresters Investment Management, exiting entirely with an estimated $3.8M sold.

  • 91 institutional investors held Exactech Inc (EXAC) as of Q4 2015, down from 102 in Q3 2015.
  • Funds reported $161M of Exactech Inc stock for Q4 2015, up 6% quarter-over-quarter.
  • 6 funds opened new Exactech Inc positions in Q4 2015 and 17 closed out, a net change of -11 holders.
  • The largest Exactech Inc buyer in Q4 2015 was Wellington Management Group, an estimated $6.81M added.
  • The largest Exactech Inc seller in Q4 2015 was Foresters Investment Management, an estimated $3.8M sold.

Based on aggregated 13F filings for Q4 2015.